down arrow

Natco Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
767.90
21.05 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
35.80
36.50
36.50
36.50
36.40
36.50
Share Warrants & Outstandings
Total Reserve
5,817.30
4,837.30
4,223.70
4,067.60
3,713.60
3,421.70
Shareholder's Funds
5,853.10
4,873.80
4,263.60
4,121.60
3,773.50
3,489.00
Minority Interest
0.00
0.00
0.00
1.80
11.20
2.00
Long-Term Borrowings
0.00
0.00
0.00
0.00
0.90
0.00
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.90
0.00
Deferred Tax Assets / Liabilities
-19.20
12.40
30.10
41.30
25.90
11.60
Other Long Term Liabilities
9.3
2.8
9.3
2.00000000000001
0.799999999999997
0.800000000000011
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
70.90
85.30
95.70
99.60
90.20
71.00
Total Non-Current Liabilities
61.00
100.50
135.10
142.90
117.80
83.40
Current Liabilities
Trade Payables
235.50
263.80
161.80
146.20
255.40
217.00
Other Current Liabilities
271.20
237.40
127.60
100.80
104.40
116.40
Short Term Borrowings
363.20
165.00
404.00
265.80
315.00
386.30
Short Term Provisions
102.90
16.90
17.00
12.80
10.50
9.00
Total Current Liabilities
972.80
683.10
710.40
525.60
685.30
728.70
Total Liabilities
6,886.90
5,657.40
5,109.10
4,791.90
4,587.80
4,303.10
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
3,603.20
3,375.10
3,126.90
2,702.10
2,148.70
1,694.50
Less: Accumulated Depreciation
1,112.40
948.20
815.10
678.90
564.30
467.30
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
2,490.80
2,426.90
2,311.80
2,023.20
1,584.40
1,227.20
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
137.30
64.30
129.50
223.40
518.00
637.60
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
95.90
87.30
104.40
151.90
83.60
19.90
Long Term Loans & Advances
114.00
78.30
73.00
45.10
72.60
63.30
Other Non Current Assets
25.40
0.30
3.70
3.50
3.60
7.90
Total Non-Current Assets
2,863.40
2,657.10
2,622.40
2,447.10
2,262.20
1,955.90
Current Assets Loans & Advances
Current Investments
443.50
305.00
203.70
151.80
28.70
148.70
Inventories
700.50
742.90
762.00
798.20
558.00
529.00
Sundry Debtors
1,188.90
856.10
620.60
412.90
551.30
506.20
Cash and Bank
952.90
546.30
206.10
283.50
66.00
279.50
Other Current Assets
99.50
63.40
88.10
94.70
91.60
107.40
Short Term Loans and Advances
638.20
486.60
606.20
603.70
1,030.00
776.40
Total Current Assets
4,023.50
3,000.30
2,486.70
2,344.80
2,325.60
2,347.20
Net Current Assets (Including Current Investments)
3,050.70
2,317.20
1,776.30
1,819.20
1,640.30
1,618.50
Total Current Assets Excluding Current Investments
3,580.00
2,695.30
2,283.00
2,193.00
2,296.90
2,198.50
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
6,886.90
5,657.40
5,109.10
4,791.90
4,587.80
4,303.10
Contingent Liabilities
0.40
14.60
8.00
1.20
1.10
2.80
Total Debt
363.20
165.00
404.00
265.80
315.90
386.30
Book Value per share (adjusted)
0
267.06
233.62
225.84
207.34
191.18
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is 120.12% vs -59.16% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is 232.14% vs -69.89% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is 5.50% vs 2.04% in Mar 2023

stock-summary

Investments

YoY Growth in year ended Mar 2024 is 9.85% vs -16.38% in Mar 2023

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is 34.10% vs 20.65% in Mar 2023

Compare Balance Sheet Results of Natco Pharma
Markets Mojo
Figures in Rs cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
35.80
40.06
-4.26
-10.63%
Share Warrants & Outstandings
Total Reserve
5,817.30
9,299.78
-3,482.48
-37.45%
Shareholder's Funds
5,853.10
9,363.09
-3,509.99
-37.49%
Minority Interest
0.00
212.70
-212.70
-100.00%
Long-Term Borrowings
0.00
24.87
-24.87
-100.00%
Secured Loans
0.00
24.87
-24.87
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-19.20
8.67
-27.87
-321.45%
Other Long Term Liabilities
9.30
30.68
-21.38
-69.69%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
70.90
123.12
-52.22
-42.41%
Total Non-Current Liabilities
61.00
187.34
-126.34
-67.44%
Current Liabilities
Trade Payables
235.50
1,102.99
-867.49
-78.65%
Other Current Liabilities
271.20
456.26
-185.06
-40.56%
Short Term Borrowings
363.20
171.17
192.03
112.19%
Short Term Provisions
102.90
389.31
-286.41
-73.57%
Total Current Liabilities
972.80
2,119.73
-1,146.93
-54.11%
Total Liabilities
6,886.90
11,882.86
-4,995.96
-42.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3,603.20
5,775.71
-2,172.51
-37.61%
Less: Accumulated Depreciation
1,112.40
1,354.82
-242.42
-17.89%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2,490.80
4,420.89
-1,930.09
-43.66%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
137.30
207.09
-69.79
-33.70%
Intangible assets under development
0.00
74.70
-74.70
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
95.90
315.12
-219.22
-69.57%
Long Term Loans & Advances
114.00
163.97
-49.97
-30.48%
Other Non Current Assets
25.40
13.79
11.61
84.19%
Total Non-Current Assets
2,863.40
5,314.63
-2,451.23
-46.12%
Current Assets Loans & Advances
Current Investments
443.50
2,258.11
-1,814.61
-80.36%
Inventories
700.50
1,553.46
-852.96
-54.91%
Sundry Debtors
1,188.90
848.28
340.62
40.15%
Cash and Bank
952.90
1,197.97
-245.07
-20.46%
Other Current Assets
99.50
106.80
-7.30
-6.84%
Short Term Loans and Advances
638.20
610.77
27.43
4.49%
Total Current Assets
4,023.50
6,568.23
-2,544.73
-38.74%
Net Current Assets (Including Current Investments)
3,050.70
4,448.50
-1,397.80
-31.42%
Total Current Assets Excluding Current Investments
3,580.00
4,310.11
-730.11
-16.94%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
6,886.90
11,882.86
-4,995.96
-42.04%
Contingent Liabilities
0.40
116.23
-115.83
-99.66%
Total Debt
363.20
196.04
167.16
85.27%
Book Value per share (adjusted)
0.00
233.73
-233.73
-100.00%
Annual - Borrowings
Borrowings 363.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 120.12% vs -59.16% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 9.30 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 232.14% vs -69.89% in Mar 2023

Annual - Fixed Assets
Fixed Assets 2,628.10 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 5.50% vs 2.04% in Mar 2023

Annual - Investments
Investments 95.90 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 9.85% vs -16.38% in Mar 2023

Annual - Current Assets
Current Assets 4,023.50 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 34.10% vs 20.65% in Mar 2023